Yale University
New Haven, Connecticut, 06510, United States
NCT Number: NCT03539107
This study will compare voiding assessment based on a minimum spontaneous voided volume of 150 cc with the standard retrograde fill approach in women after pelvic floor procedures.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
New Haven, Connecticut, 06510, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will have their bladder retrograde filled with 300mL of fluid prior to a voiding trial.
Subjects will not have retrograde fill of bladder, rather will be required to void 150 mL spontaneously prior to discharge.
Time frame: Up to 2 days post op
The percentage of subjects who did not meet the required voiding assessment criteria and needed catheterization .
Time frame: up to 30 days after discharge.
The percentage of women who initially met the voiding assessment but returned for re-catheterization due to voiding difficulty .
Time frame: Up to 2 days post op.
Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow).
Time frame: Up to 2 days post-surgery.
Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow).
Time frame: Up to 2 days post-surgery.
This question asks "How satisfied were you with the method we used to evaluate how well you could urinate after our surgery?" It is measured on a continuum from 0 (very dissatisfied) to 100 (very satisfied).
Time frame: Up to 2 days post-surgery.
This question asks "Did you experience any negative emotions such as fear or anxiety when we were evaluating urination after our surgery?" It is measured on a continuum from 0 (many negative emotions) to 100 (no negative emotions).
Time frame: Up to 2 days post-surgery.
This question asks "How likely would you be to recommend to a friend or family member, the method we used to evaluate your urination after our surgery, if they were in the same situation?" It is measured on a continuum from 0 (very unlikely) to 100 (very likely).
Time frame: Up to 2 days post-surgery.
This question asks "How convenient was the method we used to evaluate your urination after our surgery (e.g. time, ease etc.)? It is measured on a continuum from 0 (very inconvenient) to 100 (very convenient).
Time frame: Up to 2 days post-surgery.
This question asks the patient: "If it was all up to you, which It is measured on a continuum from 0 (strongly prefer backfill before catheter) to 100 (strongly prefer no backfill before catheter removal).
Time frame: One day post-surgery.
This outcome is measured by a 10-point visual analog scale where 0= no pain, 10=worst pain you have ever experienced.
Time frame: Up to 30 days post surgery.
UTI is defined as culture-proven bladder infection or, in the absence of a culture, clinical suspicion of a bladder infection that resulted in treatment.
Time frame: Up to 30 days post-surgery.
Post-operative complications assessed by medical record review.
Time frame: Up to 2 days post-surgery.
Length of hospital stay assessed by medical record review.
Yale University
Other
Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05312047
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Badalona, Barcelona, Spain
View Trial DetailsNCT01632839
Behavior, Digestive System Diseases
Clamart, France
View Trial DetailsNCT06210477
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Taipei, Taiwan
View Trial DetailsNCT05567900
Behavior, Behavior, Health
Pécs, Baranya, Hungary
View Trial Details